NCT07340489 2026-01-14
Serplulimab for Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
Clinical Trials
5 trialsNCT07167160 2025-12-18
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Recruiting
NCT07244965 2025-11-24
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Not yet recruiting
NCT04188847 2022-03-15
First-line Chemotherapy for Recurrent Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Completed
NCT04635956 2020-11-19
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
Peking Union Medical College Hospital
Phase 2 Unknown